ライフサイエンスコーパス: IVGTT

1 IVGTT-derived insulin sensitivity was reduced by (means

2 Glucose disposal during an IVGTT depends on a complex interaction of both insulin-d

3 tion (rate of glucose uptake [Rd]) during an IVGTT is more similar to the dynamics of the interstitia

4 perfectly normal glucose disposal during an IVGTT with no differences when compared with nondiabetic

5 ng not-fasting glycemia and by performing an IVGTT on days 15 and 30 post-Tx.

6 ynamic responses of glucose or insulin to an IVGTT is an important risk factor for type 2 diabetes.

7 An OGTT and IVGTT were repeated during the 12th week of treatment.

8 etes during the trial returned for OGTTs and IVGTTs 8 months after study medications were stopped.

9 ed data from a total of 280 paired OGTTs and IVGTTs during a median follow-up of 46 months.

10 ghest diastolic blood pressures and the best IVGTT insulin responses during baseline testing.

11 t reduction in the total insulin area during IVGTTs, which was highly significant (P < 0.001), and wi

12 ractional glucose disappearance rates during IVGTTs (P = 0.28).

13 f blood glucose values) were calculated from IVGTT results.

14 initial values of S(I) and S(G) derived from IVGTT's performed at study entry, there was a 10- to 20-

15 After baseline oral (OGTT) and intravenous (IVGTT) glucose tolerance testing, subjects were assigned

16 SI, calculated by minimal model analysis of IVGTT results, changed by only 4 +/- 14% during 12 weeks

17 d decreased GSIS in the first few minutes of IVGTT.

18 Two sets of IVGTTs were performed.

19 d intravenous glucose tolerance tests (OGTT; IVGTT), hyperinsulinemic-euglycemic clamps, and measurem

20 are not analogous to those from the clamp or IVGTT.

21 phase insulin release from either the HGC or IVGTT.

22 For the paired IVGTT based on 33% extraction, the area under the insuli

23 al insulin levels were matched in the paired IVGTTs by adjusting the portal insulin dose in proportio

24 ors of postpartum IGT were a low first-phase IVGTT insulin response (P = 0.0001), a diagnosis of GDM

25 Intravenous glucose tolerance test IVGTT and OGTT insulin secretion rate (ISR) and sensitiv

26 EHC), by intravenous glucose tolerance test (IVGTT) and by oral glucose tolerance test (OGTT) in 3 di

27 olism by intravenous glucose tolerance test (IVGTT) and euglycemic-hyperinsulinemic clamp.

28 from an intravenous glucose tolerance test (IVGTT) and hyperglycemic clamp (HGC) in 17 nondiabetic s

29 The intravenous glucose tolerance test (IVGTT) and hyperglycemic clamp characterized the insulin

30 An intravenous glucose tolerance test (IVGTT) in the control group (n=24) and the Cudt group (n

31 s of the intravenous glucose tolerance test (IVGTT) to document progression of resistance.

32 in-vivo Intravenous Glucose Tolerance Test (IVGTT).

33 (I.V.) glucose (I.V. glucose tolerance test [IVGTT]), arginine and glucose-potentiated arginine (gluc

34 +) underwent i.v. glucose tolerance testing (IVGTT) between the years 1964-82.

35 during intravenous glucose tolerance tests (IVGTT) remains critical for stringent evaluation of nove

36 Intravenous glucose tolerance tests (IVGTTs) for assessment of insulin sensitivity and beta-c

37 mulated intravenous glucose tolerance tests (IVGTTs) in anesthetized dogs to test the following hypot

38 Ts) and intravenous glucose tolerance tests (IVGTTs) were performed at 15-month intervals for up to 5

39 Intravenous glucose tolerance tests (IVGTTs) were performed at baseline and 3 months later to

40 odified intravenous glucose tolerance tests (IVGTTs) were performed in dogs in which insulin was admi

41 during intravenous glucose tolerance tests (IVGTTs).

42 on [via intravenous-glucose-tolerance tests (IVGTTs)].Fifty-four participants completed the study [35

43 on was restored in type 2 diabetic after the IVGTT (Phi1 x 10: 104 +/- 54 vs 228 +/- 88; P < 0.05, pr

44 using the acute insulin response during the IVGTT (AIRG).

45 was correlated with S(i) estimated from the IVGTT and the HGC (r = 0.59 and 0.76, respectively; P <

46 icularly within the first few minutes of the IVGTT, with a significantly lower area under the excursi

47 In vivo studies using the IVGTT and the hyperglycemic clamp in Sprague Dawley rats

48 For these latter three IVGTTs, the exogenous glucose bolus was labeled with 3-[

49 Acute insulin response to IVGTT (AIR(GLU) ) and GPAIS (AIR(max) ) were the most ac

50 lin (SI) levels, and i.v. glucose tolerance (IVGTTs).

51 in women with the largest reduction in total IVGTT insulin area after 1 year of treatment.